Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Kohl fights for more FDA funding

This article was originally published in The Tan Sheet

Executive Summary

FDA would receive $275 million additional funding this year to address import safety oversight, improve its information technology systems and implement new safety initiatives under an amendment Sen. Herb Kohl, D-Wis., chairman of the FDA appropriations subcommittee, added to the fiscal 2008 emergency war funding/supplemental appropriations bill passed by the House, H.R. 2764. The bill is slated for May 15 Senate Appropriations Committee markup. Of the total, $100 million is allocated to drug and medical device safety activities, $125 million will go to food safety activities and $40 million will be put towards modernizing FDA science and its workforce, issues considered at an April committee hearing ("The Tan Sheet," April 21, 2008, p. 5). Kohl said the additional funding would support efforts including opening two FDA offices overseas; implementing pediatric drug safety; and hiring 99 medical product safety inspectors...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel